We’re excited to share our latest progress!
So far, 91 patients have been successfully randomized 🎉
Our network continues to grow, with 31 active sites across 6 countries: Spain, United Kingdom, Belgium, Germany, New Zealand, Switzerland 🌍
✅ Ethics Committee approval has recently been obtained in Israel and for additional sites in Spain.
🔜 Trial set-up and EC submission in Australia are currently underway.
More updates coming soon — a big thank-you to all participating teams for helping move this trial forward! 🚀